274. 骨形成不全症 Osteogenesis Imperfecta Clinical trials / Disease details

臨床試験数 : 91 / 薬物数 : 101 - (DrugBank : 20) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 48

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04545554 (ClinicalTrials.gov)	January 21, 2021	4/9/2020	Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta	An Open-label, Ascending Multiple-dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and ...	Osteogenesis Imperfecta	Drug: Romosozumab;Dietary Supplement: Calcium;Dietary Supplement: Vitamin D	Amgen	NULL	Active, not recruiting	5 Years	17 Years	All	25	Phase 1	United States;Austria;Germany;Greece;Hungary;Italy;Spain;Turkey
2	NCT01713231 (ClinicalTrials.gov)	September 2012	21/10/2012	Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta	Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta	Osteogenesis Imperfecta	Dietary Supplement: standard-dose vitamin D(400IU per day);Dietary Supplement: high-dose vitamin D(2 ...	Louis-Nicolas Veilleux Ph.D.	NULL	Completed	6 Years	19 Years	Both	60	Phase 4	Canada

First Previous1Next Last